
NeoBiotechnologies is a leading biotechnology company based in Union City, California, specializing in the development and manufacture of highly validated monoclonal and recombinant antibodies for research, diagnostics, and commercial applications. Unlike many suppliers in the market, NeoBiotechnologies is an original manufacturer — designing, producing and validating its own antibodies in‑house rather than reselling products from third parties.
At the heart of the company’s mission is scientific rigor, reproducibility and reliability. Through stringent quality controls, including advanced proteome‑wide validation platforms, NeoBiotechnologies ensures each antibody delivers exceptional specificity and performance — a fundamental requirement for accurate biological research in fields such as cancer biology, immunology, neuroscience and signal transduction studies.
Today, NeoBiotechnologies offers an expansive portfolio of more than 10,000 unique monoclonal and recombinant antibody products covering a wide spectrum of targets across the human proteome. These reagents are meticulously screened and validated for key applications including Western blotting, immunohistochemistry (IHC), immunofluorescence, flow cytometry and more, providing researchers with powerful tools to explore protein expression, cellular pathways and disease mechanisms.
What sets NeoBiotechnologies apart is its commitment to monospecificity and reproducibility. Less than 2 % of candidate antibodies screened reach commercial release — reflecting a commitment to quality that helps researchers minimize false positives and increase experimental confidence.
In addition to its catalogue offerings, NeoBiotechnologies supports bulk supply, custom formulations, licensing and OEM partnerships, accommodating the needs of academic laboratories, diagnostic developers and biotech and pharmaceutical enterprises worldwide.
NeoBiotechnologies stands as a trusted partner in life science research, providing precisely validated reagents that empower scientists to achieve reliable, reproducible results — accelerating discoveries that drive innovation and impact human health.